In the financial year 2018 Deutsche Apotheker- und Ärztebank (apoBank) achieved a stable net income after taxes of €62.9m (2017: € 61.9 million). Based on this, a digital platform will be launched, which will communicate third-party services in the healthcare market and networks stakeholders in a way that benefits all parties.
In 2018, apoBank continued its growth course in the healthcare market. The number of customers rose to 458,770 (2017: 436,260), of which 113,455 are also members and therefore owners of the bank (2017: 111,494).
In 2019, apoBank will continue to pursue its three strategic priorities of increasing market share in start-up financing, intensifying corporate customer business and expanding asset and investment advisory services for clients. The growing customer business flanks them with process optimisation and investments in modern IT.
Thomas Siekmann, chief financial officer of apoBank said: "The results in the financial year 2018 show that it is possible to combine growth with prudent risk policy and to be sustainably profitable. This was confirmed not least by the ECB in last year's stress test, which we completed with a good result."
The new apoPrivat brand, which bundles all the offers of investment advice, has been well received by health professionals. The bank thus gained new clients as well as new mandates in asset management, especially with the new product apoVV SMART.
apoBank expects stable net income for the business development in 2019. It plans to further strengthen its capital base and distribute a stable dividend to its members.